Michał Wójcicki

Dr. Michał Wójcicki

Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Dolnośląskie, Poland
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Food and Chemical Toxicology
Verified
Journal Article
Open access
PŚPaulina Średnicka
Paulina Średnicka
Edyta Juszczuk-KubiakEdyta Juszczuk-Kubiak
Edyta Juszczuk-Kubiak
Michał WójcickiMichał Wójcicki
Michał Wójcicki
MAMonika Akimowicz
Monika Akimowicz
MRMarek Roszko
Marek Roszko
Nowadays, people are exposed to diverse environmental and chemical pollutants produced by industry and agriculture. Food contaminations such as persistent organic pollutants (POPs), heavy metals, and mycotoxins are a serious concern for global food safety with economic and public health implications especially in the newly industrialized countries (NIC). Mounting evidence indicates that chronic exposure to food contaminants referred to as xenobiotics exert a negative effect on human health such as inflammation, oxidative stress, and intestinal disorders linked with perturbation of the composition and metabolic profile of the gut microflora. Although the physicochemical technologies for food decontamination are utilized in many cases but require adequate conditions which are often not feasible to be met in many industrial sectors. At present, one promising approach to reduce the risk related to the presence of xenobiotics in foodstuffs is a biological detoxification done by probiotic strains and their enzymes. Many studies confirmed that probiotics are an effective, feasible, and inexpensive tool for preventing xenobiotic-induced dysbiosis and alleviating their toxicity. This review aims to summarize the current knowledge of the direct mechanisms by which probiotics can influence the detoxification of xenobiotics. Moreover, probiotic-xenobiotic interactions with the gut microbiota and the host response were also discussed.

31 December 2019 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
OŚOlga Świder
Olga Świder
MRMarek Roszko
Marek Roszko
Michał WójcickiMichał Wójcicki
Michał Wójcicki
KSKrystyna Szymczyk
Krystyna Szymczyk

25 July 2025 in Journal of General Virology
Verified
Journal Article
Open access
University EnglandUniversity England
University England
EAEvelien Adriaenssens
Evelien Adriaenssens
RARudolf I. Amann
Rudolf I. Amann
PBPavol Bardy
Pavol Bardy
NBNina Bartlau
Nina Bartlau
ICICTV Taxonomy Summary Consortium
ICTV Taxonomy Summary Consortium
This article summarises the activities of the International Committee on Taxonomy of Viruses Bacterial Viruses Subcommittee, detailing developments in the classification of bacterial viruses. We provide here an overview of all new, abolished, moved and renamed taxa proposed in 2024, approved by the Executive Committee, and ratified by membership vote in 2025. Through the collective efforts of 74 international contributors of taxonomy proposals in this round, 43 ratified proposals have led to the creation of one new phylum, one class, four orders, 33 families, 14 subfamilies, 194 genera and 995 species. These proposals mark significant progress in refining the taxonomy of bacterial viruses. Key updates include the creation of new orders and families that include existing taxa to better reflect genomic and evolutionary relationships. As sequencing and bioinformatics approaches continue to advance, further expansion and refinements in viral taxonomy can be anticipated in the coming years.

8 November 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
IGIlona Grygiel
Ilona Grygiel
OBOlaf Bajrak
Olaf Bajrak
Michał WójcickiMichał Wójcicki
Michał Wójcicki
KKKlaudia Krusiec
Klaudia Krusiec
EJEwa Jończyk-Matysiak
Ewa Jończyk-Matysiak
SLSławomir Letkiewicz
Sławomir Letkiewicz
Acinetobacter baumannii—a multidrug-resistant (MDR) pathogen that causes, for example, skin and soft tissue wounds; urinary tract infections; pneumonia; bacteremia; and endocarditis, particularly due to its ability to form robust biofilms—poses a significant challenge in clinical settings. This structure protects the bacteria from immune responses and antibiotic treatments, making infections difficult to eradicate. Given the rise in antibiotic resistance, alternative therapeutic approaches are urgently needed. Bacteriophage-based strategies have emerged as a promising solution for combating A. baumannii biofilms. Phages, which are viruses that specifically infect bacteria, offer a targeted and effective means of disrupting biofilm and lysing bacterial cells. This review explores the current advancements in bacteriophage therapy, focusing on its potential for treating A. baumannii biofilm-related infections. We described the mechanisms by which phages interact with biofilms, the challenges in phage therapy implementation, and the strategies being developed to enhance its efficacy (phage cocktails, engineered phages, combination therapies with antibiotics). Understanding the role of bacteriophages in both biofilm disruption and in inhibition of its forming could pave the way for innovative treatments in combating MDR A. baumannii infections as well as the prevention of their development.

24 June 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
Michał WójcickiMichał Wójcicki
Michał Wójcicki
OŚOlga Świder
Olga Świder
KDKamila J. Daniluk
Kamila J. Daniluk
PŚPaulina Średnicka
Paulina Średnicka
MAMonika Akimowicz
Monika Akimowicz
Edyta Juszczuk-KubiakEdyta Juszczuk-Kubiak
Edyta Juszczuk-Kubiak
The widespread use of antibiotics, especially those with a broad spectrum of activity, has resulted in the development of multidrug resistance in many strains of bacteria, including Salmonella. Salmonella is among the most prevalent causes of intoxication due to the consumption of contaminated food and water. Salmonellosis caused by this pathogen is pharmacologically treated using antibiotics such as fluoroquinolones, ceftriaxone, and azithromycin. This foodborne pathogen developed several molecular mechanisms of resistance both on the level of global and local transcription modulators. The increasing rate of antibiotic resistance in Salmonella poses a significant global concern, and an improved understanding of the multidrug resistance mechanisms in Salmonella is essential for choosing the suitable antibiotic for the treatment of infections. In this review, we summarized the current knowledge of molecular mechanisms that control gene expression related to antibiotic resistance of Salmonella strains. We characterized regulators acting as transcription activators and repressors, as well as two-component signal transduction systems. We also discuss the background of the molecular mechanisms of the resistance to metals, regulators of multidrug resistance to antibiotics, global regulators of the LysR family, as well as regulators of histone-like proteins.

10 November 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
Michał WójcickiMichał Wójcicki
Michał Wójcicki
ACAgnieszka Chmielarczyk
Agnieszka Chmielarczyk
OŚOlga Świder
Olga Świder
PŚPaulina Średnicka
Paulina Średnicka
MSMagdalena Strus
Magdalena Strus
Edyta Juszczuk-KubiakEdyta Juszczuk-Kubiak
Edyta Juszczuk-Kubiak
Salmonella is one of the most important foodborne pathogens. Fifty-three strains of Salmonella deposited in the Culture Collection of Industrial Microorganisms—Microbiological Resources Center (IAFB) were identified using molecular and proteomic analyses. Moreover, the genetic similarity of the tested strains was determined using the PFGE method. Main virulence genes were identified, and phenotypical antibiotic susceptibility profiles and prevalence of resistance genes were analyzed. Subsequently, the occurrence of the main mechanisms of β-lactam resistance was determined. Virulence genes, invA, fimA, and stn were identified in all tested strains. Phenotypic tests, including 28 antibiotics, showed that 50.9% of the strains were MDR. The tet genes associated with tetracyclines resistance were the most frequently identified genes. Concerning the genes associated with ESBL-producing Salmonella, no resistance to the TEM and CTX-M type was identified, and only two strains (KKP 1597 and KKP 1610) showed resistance to SHV. No strains exhibited AmpC-type resistance but for six Salmonella strains, the efflux-related resistance of PSE-1 was presented. The high number of resistant strains in combination with multiple ARGs in Salmonella indicates the possible overuse of antibiotics. Our results showed that it is necessary to monitor antimicrobial resistance profiles in all food chain links constantly and to implement a policy of proper antibiotic stewardship to contain or at least significantly limit the further acquisition of antibiotic resistance among Salmonella strains.